Research Roundup

Debbie Rigby takes a look at the latest in research news Pandora’s box: Paxlovid, prescribing, pharmacists and pandemic This editorial provides practical guidance on identifying and managing drug interactions with nirmatrelvir/ritonavir (Paxlovid), an oral antiviral reported to reduce COVID-19-related hospital admission or death from any cause by 89% relative to placebo in unvaccinated adults with

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Groundhog day’ as antipsychotic use, polypharmacy revealed
Next Independents merge